

![]() |
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin |
|
Authors | ||
Published in | Journal of thrombosis and haemostasis. 2011, vol. 9, no. 10, p. 2109-11 | |
Keywords | Aspirin/pharmacology — Enzyme Inhibitors/pharmacology — Humans — Platelet Aggregation Inhibitors/pharmacology — Receptors, Thromboxane/antagonists & inhibitors — Thromboxane-A Synthase/antagonists & inhibitors | |
Identifiers | PMID: 21777369 | |
Full text | ||
Structures | ||
Research group | Geneva Platelet Group (13) | |
Citation (ISO format) | FONTANA, Pierre et al. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. In: Journal of thrombosis and haemostasis, 2011, vol. 9, n° 10, p. 2109-11. doi: 10.1111/j.1538-7836.2011.04446.x https://archive-ouverte.unige.ch/unige:23987 |